IP Library › Granted Patent US 10,940,130
Granted Patent B2
US 10,940,130 · App. 16/437,701 · Granted Mar 9, 2021

Compositions comprising theanine and whey protein

Inventors: Todd Henderson (Lancaster, SC); David Griffin (Forest Hill, MD); David Bledsoe (Lancaster, SC)
Assignee: NUTRAMAX LABORATORIES, INC.
A61K31/198A61K9/0053A61K31/197A61K31/4045A61K31/7076A61K36/575A61K36/756A61K38/018A61K38/38A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,940,130
App. No.
16/437,701
Granted
Mar 9, 2021
Kind
B2
Abstract

An anxiolytic composition includes a synergistic combination of an L-theanine and a whey protein composition.

Claims (10)

1. An anxiolytic composition comprising a synergistic combination of L-theanine and a whey protein provided at a ratio of about 3:1, wherein the synergistic combination provides an anxiolytic change in a release pattern of one or more neurotransmitters.

2. The anxiolytic composition of claim 1 , wherein the whey protein comprises alpha-lactalbumin.

3. The anxiolytic composition of claim 1 , wherein the neurotransmitters are brain neurotransmitters selected from the group consisting of γ-aminobutyric acid (GABA) and serotonin.

4. The anxiolytic composition of claim 1 , formulated for oral administration to a mammal.

5. The anxiolytic composition of claim 4 , wherein the mammal is selected from the group consisting of a human, a companion animal, and an equine animal.

6. A method for reducing, ameliorating, or treating symptoms of anxiety, comprising administration of a combination of L-theanine and a whey protein at a ratio of about 3:1 to a mammal whereby an anxiolytic change in a release pattern of one or more neurotransmitters is effected.

7. The method of claim 6 , further including providing the whey protein as a whey protein concentrate comprising alpha-lactalbumin.

8. The method of claim 6 , wherein the neurotransmitters are brain neurotransmitters selected from the group consisting of γ-aminobutyric acid (GABA) and serotonin.

9. The method of claim 6 , wherein the mammal is a canine or feline.

10. The method of claim 6 , wherein the mammal is an equine.

Continuity (4)
Continuation 15705435 · Sep 15, 2017
Continuation PCTUS2016049630 · Aug 31, 2016
Provisional Application 62212080 · Aug 31, 2015
Related Publication 20190290608A1 · Sep 26, 2019
Cited By (1)
US 12,194,011